Healthcare
SG slashes clinical trial red tape, speeds up health tech reviews
SG slashes clinical trial red tape, speeds up health tech reviews
It is due to launch early next year.
2 days ago
Q&M Dental profit rises 27% to $4.9m in H1
The group plans to improve revenue growth by upskilling clinicians.
3 days ago
NHG Health unveils cluster-wide cancer institute in Singapore
The hospital also signed two additional agreements.
6 days ago
SG’s CGH unveils first Nature-Based Therapy programme
During the sessions, patients are guided to observe their surroundings.
IHH backs Fortis acquisition amidst India forensic audit order
The court denied Fortis’ petition challenging a required forensic audit.
SingHealth Duke-NUS launches $6m platform to advance disease research
It aims to identify targets for lab-developed diagnostic tests.
Singapore expands regulatory reliance pacts to Africa, Malaysia and Saudi Arabia
The city-state aims to cut duplicated reviews and speed up access to health products.
Tokyo Court rejects IHH unit's claims against Daiichi Sankyo
NTK weighs legal options after ruling on case linked to Fortis tender offer delays.
MORROW opens first Singapore clinic as regional expansion plans advance
The flagship spans 45,000 sq. ft. across two floors at Longevity World.
Ageing, workforce shortages top Singapore healthcare pressures: ASEAN index
Across the region, digital transformation and AI rank as the top future pressures.
Thomson Medical cuts H2 loss by 43.9%
Other operating expenses dropped 48.7% to $61.3m.
UltraGreen.ai ready to recalibrate US medical dye strategy
The company’s response will hinge on its rivals’ pricing, distribution, and customer offer.
OUE Healthcare subject to $0.050-a-share privatisation bid
The offer is 28.2% above OUEH’s last traded price of $0.039 on 21 August.
OUE funds NTU Singapore professorship in healthcare tech
OUE endowed US$2.3m to NTU to establish the Stephen Riady Professorship.
Medi Lifestyle eyes $6.76m deal for 60% of Q&M’s EM2AI
The proposed acquisition will be paid entirely with new shares.
Foundation Healthcare H1 net profit drops 67.6% despite stronger revenue
Acquisition-related and capital-raising expenses rose to $5.36m during the period.
UltraGreen.ai H1 net profit jumps 53% on global uptake of surgical dye
Group revenue reached $111.62m despite the discontinued business.
Commentary
When scale arrives before proof: Singapore’s capital allocation question in Southeast Asia
Rethinking fleet ownership in a changing business landscape
Beyond the chips: The materials behind Singapore’s AI infrastructure
How homegrown brands are redefining premium in Asia
AI in hospitality: Where should Singapore’s F&B operators draw the line?
Do Singapore workplaces mistake silence for leadership?
AI as the new competitive advantage for Singapore’s small retailers
Singapore's next payments opportunity